# US 6,726,926 B2 · Gene-entrapped liposomes preparation and process for the preparation thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,726,926 B2
- Document ID: US6726926B2
- Status: Granted
- Kind: B2
- Application number: 09/790,727
- Filed: 2001-02-23
- Published: 2002-04-18
- Granted: 2004-04-27
- Earliest claimed: 2000-02-23
- Assignees: Kaken Pharmaceutical Co., Ltd.; Institute of Applied Biochemistry
- Inventors: Haruyoshi Yajima; Keizo Sakuda; Hideshi Ideno; Kunio Yagi; Nobuko Ohishi; Jun Yoshida
- Web page: https://patentgrep.com/patent/US6726926B2

## CPC

- A61K 31/711: Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
- A61K 9/1271: Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers (liposomes as conjugates {A61K47/6911})
- A61K 9/1272: comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers (lipids as modifying agents {A61K47/543})
- C12N 15/88: using microencapsulation, e.g. using {amphiphile} liposome vesicle
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

It provides a gene-entrapping liposome preparation which can be preserved over a long period of time, and a process for the preparation of the same. The preparation can be prepared by adding an aqueous solution of disaccharide to gene-entrapping liposomes. The frozen preparation can be preserved for 6 months or more at preservation temperature of −20° C., and the preparation shows excellent restoration ability in water and does not show reduction in biological activity. In the case of the lyophilized preparation, it can be preserved for longer time of about 1 year, shows excellent restoration ability in water, and does not show reduction in biological activity.

## Claims

### Claim 1

A gene-entrapping liposome preparation, which comprises:
liposomes wherein plasmid DNA is entrapped in said liposomes, and
a disaccharide as a protector of said liposome and said plasmid DNA entrapped therein, which disaccharide is present at a concentration ranging from 300 to 3333 g per 1 g of said plasmid DNA entrapped in said liposomes,
wherein the preparation is a frozen product obtained by freezing of the gene-entrapping liposome preparation during which cleavage of the plasmid DNA is prevented by the presence of said disaccharide added;
said liposomes are of a diameter ranging from 0.6 to 6 μm; and
constitutive lipids of said liposomes are N-(α-trimethylammonioacetyl)-didodecyl-D-glutamate chloride (TMAG), dilauroyl phosphatidylcholine (DLPC) and dioleoyl phosphatidylethanolamine (DOPE),
whereby the plasmid DNA in the gene-entrapping liposome preparation remains uncleaved.

### Claim 2

A gene-entrapping liposome preparation, which comprises:
liposomes wherein plasmid DNA is entrapped in said liposomes, and
a disaccharide as a protector of said liposome and said plasmid DNA entrapped therein, which disaccharide is present at a concentration ranging from 300 to 3333 g per 1 g of said plasmid DNA entrapped in said liposomes,
wherein the preparation is a lyophilized product obtained by lyophilization of the gene-entrapping liposome preparation during which cleavage of the plasmid DNA is prevented by the presence of said disaccharide;
said liposomes are of a diameter ranging from 0.6 to 6 μm; and
constitutive lipids of said liposomes are N-(α-trimethylammonioacetyl)-didodecyl-D-glutamate chloride (TMAG), dilauroyl phosphatidylcholine (DLPC) and dioleoyl phosphatidylethanolamine (DOPE),
whereby the plasmid DNA in the gene-entrapping liposome preparation remains uncleaved.

### Claim 3 (depends on 1, 2)

The gene-entrapping liposome preparation as claimed in claim 1 or 2, wherein said disaccharide is at least one of sucrose and lactose.

### Claim 4

A process for preparing gene-entrapping liposome preparations, which comprises:
adding an aqueous solution of a disaccharide into gene-entrapping liposomes at a concentration ranging from 300 to 3333 g per 1 g of said gene entrapped in said liposomes to form said gene entrapping liposome preparation; and
freezing or lyophilizing the gene-entrapping liposome preparation,
wherein said liposomes are of a diameter ranging from 0.6 to 6 μm, and wherein cleavage of said gene-entrapped in said liposomes is prevented during the freezing or lyophilizing step by the presence of said disaccharide.

### Claim 5 (depends on 4)

The process as claimed in claim 4, wherein constitutive lipids of said liposomes are N-(α-trimethylammonioacetyl)-didodecyl-D-glutamate chloride (TMAG), dilauroyl phosphatidylcholine (DLPC) and dioleoyl phosphatidylethanolamine (DOPE).
